Publication

Cross-validation of biomonitoring methods for polycyclic aromatic hydrocarbon metabolites in human urine: Results from the formative phase of the Household Air Pollution Intervention Network (HAPIN) trial in India

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Naveen Puttaswamy, Sri Ramachandra Institute of Higher Education & ResearchSudhakar Saidam, Sri Ramachandra Institute of Higher Education & ResearchGayathri Rajendran, Sri Ramachandra Institute of Higher Education & ResearchKokila Arumugam, Sri Ramachandra Institute of Higher Education & ResearchSavannah Gupton, Emory UniversityErin W. Williams, Emory UniversityCierra L. Johnson, Emory UniversityParinya Panuwet, Emory UniversitySarah Rajkumar, Colorado State UniversityMaggie L. Clark, Colorado State UniversityJennifer L. Peel, Colorado State UniversityWilliam Checkley, Johns Hopkins UniversityThomas Clasen, Emory UniversityKalpana Balakrishnan, Sri Ramachandra Institute of Higher Education & ResearchDana Barr, Emory University
Language
  • English
Date
  • 2020-10-01
Publisher
  • ELSEVIER
Publication Version
Copyright Statement
  • © 2020 The Authors
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 1154
Start Page
  • 122284
End Page
  • 122284
Grant/Funding Information
  • The HAPIN trial is funded by the U.S. National Institutes of Health (cooperative agreement 1UM1HL134590) in collaboration with the Bill & Melinda Gates Foundation [OPP1131279]. Additional support was provided by Emory’s NIH-funded Human Exposome Research Center (P30ES019776).
Supplemental Material (URL)
Abstract
  • The Household Air Pollution Intervention Network (HAPIN) trial is evaluating health benefits of a liquefied petroleum gas (LPG) stove intervention in biomass cook-fuel using homes (n = 3200) in four low-and middle-income countries (LMICs) that include Peru, Guatemala, Rwanda and India. Longitudinal urine samples (n = 6000) collected from enrolled pregnant women, infants and older women will be analyzed for biomarkers associated with exposure and health outcomes. We report results from cross-validation of a lower cost high-performance liquid chromatography with fluorescence detection (HPLC-FLD) method with a higher resolution liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the measurement of 1-hydroxypyrene (1PYR) and 2-naphthol (2NAP). Twenty-five split urine samples were analyzed by HPLC-FLD method at the India trial site in Chennai, India and by LC-MSMS method at the trial wide Biomarker Coordinating Center, Emory University, USA. The limits of detection (LOD) for the HPLC-FLD method were 0.02 ng/mL and 0.07 ng/mL for 2NAP and 1PYR, respectively. Bland-Altman analysis estimated a bias of 2.98 ng/ml for 2NAP (95% CI: −5.22, −0.75) and 0.09 ng/mL for 1PYR (95% CI: −0.02, 0.21) with HPLC-FLD levels being lower than LC-MSMS levels at higher concentrations. Analyses of additional urine samples (n = 119) collected during the formative phase of the HAPIN trial in India, showed 2NAP and 1PYR levels to be consistently above the limit of quantification (LOQ) and demonstrated the applicability of the method. The HPLC-FLD method can serve as a cost-effective and reliable analytical method to measure 2NAP and 1PYR in human urine in LMICs, within and beyond the HAPIN trial.
Author Notes
  • Naveen Puttaswamy: ICMR Center for Advanced Research in Air Pollution, Department of Environmental Health Engineering, Faculty of Public Health, Sri Ramachandra Institute of Higher Education and Research, Chennai 600 116, TN, India. naveen@ehe.org.in
Keywords
Research Categories
  • Biology, Molecular
  • Chemistry, Analytical
  • Chemistry, Biochemistry

Tools

Relations

In Collection:

Items